Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinluo plus metoprolol tartrate for angina pectoris in coronary heart disease
TCTR20220505005Phase 1Unknown
- Sponsor
- Pengcheng Ren
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in angina pectoris and coronary arteriosclerosis comparing Tongxinluo + metoprolol tartrate with Placebo + metoprolol tartrate (2 arms). Status: unknown.
02
Drugs
Tongxinluometoprolol
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20220505005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220505005.